Citation: D. Massel et Sh. Little, Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: A meta-analysis, J AM COL C, 37(2), 2001, pp. 569-578
Citation: D. Massel et M. Cruickshank, Greater expectations in a cancer trial: Absolute more than relative survival increases, community more than academic clinicians, CANCER INV, 18(8), 2000, pp. 798-803
Citation: D. Massel et al., Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibility, AM HEART J, 140(2), 2000, pp. 221-226
Citation: D. Massel, Similar, the same or just not different: A guide for deciding whether treatments are clinically equivalent, CAN J CARD, 15(5), 1999, pp. 556-562
Citation: Sm. Renner et al., Mediastinal irradiation: A risk factor for atherosclerosis of the internalthoracic arteries, CAN J CARD, 15(5), 1999, pp. 597-600
Citation: D. Massel, Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase, CAN J CARD, 15(2), 1999, pp. 173-179